Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Lennox-Gastaut Syndrome
Clinical trial NCT02318537 · WITHDRAWN
Trial details
- NCT number
- NCT02318537
- Sponsor
- INSYS Therapeutics Inc
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-30
- Primary completion
- 2018-06-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.